From: Field effect transistor based wearable biosensors for healthcare monitoring
Biofluids | Biomarker | Disease/application | Clinical range | Sensing probe | Gating | Semiconductor | Dynamic range | Refs. |
---|---|---|---|---|---|---|---|---|
Sweat | Ammonia | Muscular fatigue | 0.5–25 mM [128] | Ion-selective membrane | Top-gate | SWCNT | 0.01–10 mM | [41] |
Na + /K + /Ca2 +  | Monitoring sweat electrolytes | Na+:10-140 mM [129] K+:2-6 mM [129] Ca2+:30-300 mg/L [130] | Ion-selective membranes | 3D extended metal gate | SiNW | Na+:1-100 mM K+:1-50 mM Ca2+: 0.1-20 mM | [1] | |
Na + /K +  | Ovulation, cystic fibrosis, kidney failure | Na+: 10-140 mM [129] K+: 2-6 mM [129] | Ion-selective membranes | Top-gate | MOS | Na+: 5-100 mM K+: 5-50 mM | [19] | |
Na +  | Monitoring sweat electrolytes | 10-140 mM [129] | Ion-selective membranes | Side-gate | SWCNT | 0.1-100 mM | [123] | |
Lactate | Monitoring lactate level | 2–65 mM [131] | Lactate oxidase, horseradish peroxidase and Osmium-redox polymer | Extended-gate | pBTTT-C16 (organic semiconductor) | LOD: 66 nM; LOQ: 220 nM | [132] | |
s-IgA | Depression | 1230 pg/mL [133] | Jacalin | Liquid-gate | Si | 0.1–100 μg/mL | [77] | |
Cortisol | Stress-related disorders | 0.1–139.9 ng mL[133] | Aptamer | Side-gate | In2O3 | 1 pM-10 μM | [17] | |
TNF-α | Inflammatory cytokine | 9.3–21.1 pg/ml [134] | Aptamer | Side-gate | Graphene | 50 pM-100 nM; LOD: 5 pM | [16] | |
Cortisol | Stress-related disorders & human performance | 0.1–139.9 ng/mL [133] | Aptamer | Extended-gate | Graphene | 1 nM—10 µM | [108] | |
Serotonin and dopamine | Monitoring multiple neurotransmitters | Not given | Aptamer | Side-gate | In2O3 | 10fM-1uM | [33] | |
Tear | Glucose | Diabetes | 0.1–0.6 mM [135] | Glucose oxidase | Back-gate and liquid gate | Graphene | 1 µM to 10 mM | [93] |
Glucose | Diabetes | 0.1–0.6 mM [135] | Glucose oxidase | Back-gate | MoS2 | 0.1–0.6 mM | [32] | |
Cortisol | Stress-related disorders & human performance | 0–1306 nM [133] | Antibody | Liquid-gate | Graphene | 1–40 ng/mL; LOD: 10 pg/mL | [2] | |
TNF-α and IFN-Y | Monitoring inflammatory cytokines | TNF-α: 1.1–21.7 pg/mL [136] IFN-Y: 3–12 pg/mL[137] | Aptamer | Side-gate | Graphene | TNF-α: 0.03–500 nM, LOD: 2.75 pM INF-Y: 0.03–500 nM, LOD: 2.89 pM | [138] | |
Matrix metalloproteinase-9 | Chronic ocular surface inflammation | 3–41 ng/mL [139] | Antibody | Back-gate and liquid gate | Graphene | 1–500 ng/ml | [140] | |
Saliva | Ammonia | Metabolism, mouth bacteria | Not given | Ion-selective membranes | Liquid-gate | zinc titanium oxide | 10–4 – 1 M | [21] |
Cortisol | Stress-related disorders and human performance | 0.1–139.9 ng/mL [133] | Aptamer | Liquid-gate | Graphene | 0.01–104 nM | [81] | |
Oxytocin | Monitoring of neurotransmitter; lactating women | 6.44–61.05 pg/ml [141] | Antibody | Extended-gate | C6-DNT-VW/polystyren (organic semiconductor) | LOD: 3.9 pg/mL | [40] | |
Carbonic anhydrase 1 | Cancers, pancreatitis, diabetes and Sjogren's syndrome | Not given | Aptamer | Liquid gate | Graphene | 10Â pg/ml-100Â ng/ml | [142] | |
ISF | Na+ | Dysnatremia | 145 mM [143] | Ion-selective membranes | Extended-gate | not given | 10–160 mM; LOD: 2.78 μM | [144] |
C-Reactive Protein | Inflammation | Not given | Antibody Fab fragment | Back-gate and liquid gate | SiNW | 60 ng/mL-100 μg/mL | [35] | |
Glucose | diabetes | 2.1–23.4 mM [145] | Glucose oxidase | Back-gate | ZnO | 1 μM-10 mM | [44] |